TABLE 1.
Treatment and outcomes within 90 days following CIA diagnosis
| No Anemia Treatment | RBC only | ESA only | RBC and ESA | Total Patients | |
|---|---|---|---|---|---|
| Patients with VTE / (All patients) | 2043 / (7878) = 25.9% | 545 / (2008) = 27.1% | 42 / (246) = 17.1% | 12 / (137) = 8.8% | 2642 / (10 269) = 25.7% |
| HR = 1.37, 95% CI 1.24‐1.50, P < .001 | HR = 0.53, 95% CI 0.40‐0.69, P < .001 | ||||
| Men with VTE /(All male patients) | 1056 / (3898) = 27.1% | 276 / (1044) = 26.4% | 17 / (94) = 18.1% | 3 / (64) = 4.7% | 1352 /(5100) = 26.5% |
| HR = 1.24, 95% CI 1.09‐1.41, P = .001 | HR = 0.47, 95% CI 0.30‐0.73, P = .001 | ||||
| Women with VTE / (All female patients) | 987 / (3979) = 24.8% | 269 / (964) = 27.9% | 25 / (152) = 16.4% | 9/ (73) = 12.3% | 1290 / (5168) = 25.0% |
| HR = 1.51, 95% CI 1.32‐1.72, P < .001 | HR = 0.58, 95% CI 0.41‐0.81, P = .002 | ||||
| Age < 65 with VTE / (All patients < 65) | 900 / (3335) = 27.0% | 238 / (907) = 26.2% | 15 / (72) = 20.8% | 4 / (51) = 7.8% | 1157 / (4365) = 26.5% |
| HR = 1.26, 95% CI 1.09‐1.45, P = .001 | HR = 0.57, 95% CI 0.36‐0.89, P = .015 | ||||
| Age 65+ with VTE / (All patients 65+) | 1143 / (4543) = 25.2% | 307 / (1101) = 27.9% | 27 / (174) = 15.5% | 8 / (86) = 9.3% | 1485 / (5904) = 25.2% |
| HR = 1.45, 95% CI 1.28‐1.64, P < .001 | HR = 0.51, 95% CI 0.37‐0.72, P < .001 |
Note: In the above table, each value listed as (x / y), x pertains to all patients who received the specified treatment who had a VTE, while y pertains to all patients who received the specified treatment.